HCA Healthcare Stock Forecast
NYSE: HCAHealth CareHospital/Nursing ManagementUSD
Market open · Delayed 15 min · as of Oct 8, 3:07 PM ET
HCA analyst consensus
Consensus (26 analysts)
buy
Avg. price target
$459.27+3.00%
- Strong buy 1
- Buy 14
- Hold 10
- Sell 1
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 26 Wall Street analysts covering HCA Healthcare (2026-10-07), 15 rate the stock a buy or strong buy, 10 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $459.27, with a high estimate of $579.00 and a low estimate of $380.00. The average target implies upside of 3.0% from the current price of $445.91.
The spread between the highest and lowest targets is 52.4%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for HCA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 4% |
| Buy | 14 | 54% |
| Hold | 10 | 38% |
| Sell | 1 | 4% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-07.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $380.00 | -14.78% |
| Average target | $459.27 | +3.00% |
| High target | $579.00 | +29.85% |